[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354279-105":3,"doc-detail-354279-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-absence-of-b7-h4-inhibits-pd-l1-expression-by-driving-a-methylation-of-pd-l1-promoter-in-breast-cancer-cells","The absence of B7-H4 inhibits PD-L1 expression by driving a methylation of PD-L1 promoter in breast cancer cells","","B7-H4 is a co-inhibitory molecule elevated in breast cancer and linked to prognosis and therapeutic relevance, yet its relationship with PD-L1 remains debated. This study shows that B7-H4 upregulates PD-L1 transcription by reducing DNMT1-mediated methylation at specific PD-L1 promoter CpG loci, and supports IFN-γ-driven PD-L1 induction. DNMT1 inhibition enhances IFN-γ responsiveness, while B7-H4/PD-L1 co-expression associates with increased CD8A, GZMB, and PRF1 and improved disease-free survival, suggesting epigenetic therapy potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-absence-of-b7-h4-inhibits-pd-l1-expression-by-driving-a-methylation-of-pd-l1-promoter-in-breast-cancer-cells/354279/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-absence-of-b7-h4-inhibits-pd-l1-expression-by-driving-a-methylation-of-pd-l1-promoter-in-breast-cancer-cells/354279.png","ImageObject",300,407,{"name":42,"@type":43},"Dipper","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the central finding about B7-H4 and PD-L1 in breast cancer?","Question",{"text":63,"@type":64},"The absence of B7-H4 inhibits PD-L1 expression by affecting methylation of the PD-L1 promoter in breast cancer cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does B7-H4 regulate PD-L1 at the mechanistic level?",{"text":68,"@type":64},"B7-H4 promotes PD-L1 transcription by downregulating DNMT1-mediated methylation at specific CpG loci in the PD-L1 promoter.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the clinical significance of co-expression of B7-H4 and PD-L1?",{"text":72,"@type":64},"Co-expression correlates with higher T-cell–related markers (CD8A, GZMB, PRF1), indicating increased immune infiltration, and is associated with improved disease-free survival.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354279,1790214360,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd",8,"Zhou et al. Breast Cancer Research (2026) 28:106 Breast Cancer Research  \n[https://doi.org/10.1186/s13058-026-02289-6](https://doi.org/10.1186/s13058-026-02289-6)  \nRESEARCH Open Access  \nThe absence of B7-H4 inhibits PD-L1 expression by driving a methylation of PD-L1 promoter in breast cancer cells  \nLinlin Zhou1*, Mei Ruan2, Jichun Wu3, Qiongwen Wu1, Yonglei Xiao1, Chen-Wei Yu4 and Qiuyu Zhang1*  \nAbstract  \nThe expression of B7-H4, a co-inhibitory molecule highly detected in cancer cells, serves as an important prognostic marker and therapeutic target in breast cancer. B7-H4 has been shown to modulate the malignancy of breast cancer cells through affecting cell stemness and the epithelial-mesenchymal transition (EMT) . However, whether B7-H4 influences the expression of other immunoregulatory molecules, and how this crosstalk contributes to the clinicopathological features of breast cancer remain controversial. Although the majority of the tumors are positive for B7-H4 and negative for PD-L1, we noticed a portion of breast tumor cells (4 .3–18. 8%) showing co-expression of two molecules. Besides, there is an overall positive correlation in the expression of B7-H4 and PD-L1 in breast cancer. Mechanistically, B7-H4 promotes the transcription of PD-L1 via downregulating the DNA methyltransferase 1 (DNMT1)-mediated methylation in cg19724470 and cg15837913 CpG loci in the promoter of PD-L1 . Moreover, the expression of B7-H4 is negatively associated with the methylation levels of these two  \nloci in a breast cancer cohort in the TCGA database, and is necessary for interferon-γ (IFN-γ)-induced PD-L1 expression in breast cancer cells. Pharmacological inhibition of DNMT1 improves IFN-γ responsiveness in breast cancer cells. Functionally, individuals with co-expression of B7-H4 and PD-L1 present higher abundance of CD8A, granzyme B (GZMB) and perforin 1 (PRF1) than those without co-expression in tumor tissues, indicating increased T cell infiltration in these patients. Consistently, the co-expression of these two molecules is also associated with improved disease-free survival in breast cancer patients. Overall, our study unveils a mechanistic link between B7-H4 and PD-L1 expression through DNA methylation-mediated epigenetic regulation in breast cancer, and indicates that epigenetic therapy holds potential in remodeling the immune landscape and overcoming treatment resistance in breast cancer.  \nKeywords B7-H4, Breast cancer, PD-L1, Methylation, DNMT1  \n*Correspondence:  \nLinlin Zhou [zhoulinlin@fjmu.edu.cn](zhoulinlin@fjmu.edu.cn)[ ](zhoulinlin@fjmu.edu.cn)Qiuyu Zhang [qiuyu.zhang@fjmu.edu.cn](qiuyu.zhang@fjmu.edu.cn)  \n1Institute of Immunotherapy, Fujian Medical University, Fuzhou, China 2Department of Hepatobiliary Internal Medicine, The Third Affiliated People‘s Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, China  \n3Laboratory Animal Center, Fujian Medical University, Fuzhou, China 4Department of Statistics and Information Science, Fu Jen Catholic University, New Taipei City, Taiwan  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from th","cbCaiplQzLRlwlzl","https://ap.wps.com/l/cbCaiplQzLRlwlzl","pdf",10930587,19,"English","# Abstract\n# Introduction","[{\"question\":\"What is the central finding about B7-H4 and PD-L1 in breast cancer?\",\"answer\":\"The absence of B7-H4 inhibits PD-L1 expression by affecting methylation of the PD-L1 promoter in breast cancer cells.\"},{\"question\":\"How does B7-H4 regulate PD-L1 at the mechanistic level?\",\"answer\":\"B7-H4 promotes PD-L1 transcription by downregulating DNMT1-mediated methylation at specific CpG loci in the PD-L1 promoter.\"},{\"question\":\"What is the clinical significance of co-expression of B7-H4 and PD-L1?\",\"answer\":\"Co-expression correlates with higher T-cell–related markers (CD8A, GZMB, PRF1), indicating increased immune infiltration, and is associated with improved disease-free survival.\"}]","The absence of B7-H4 inhibits PD-L1 expression by driving a methylation of PD-L1 promoter in breast cancer cells | PDF",1790109841,48,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67b82c2377639395ed1db9117253a29e.webp",983,1310,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/129b25f7c7d2198dc3a7e190595273ff.webp",982,1309,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/91b74d817a292efac469c38bdef8c23a.webp",981,1308,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75c2908aba374cbdbac71b2abbb45f11.webp",980,1306,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,145,148,153,156,160],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":141,"doc_module":4,"doc_module_name":25,"category_name":142,"show_sort_weight":143,"slug":144},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":146,"slug":147},30,"research-report",{"id":149,"doc_module":4,"doc_module_name":25,"category_name":150,"show_sort_weight":151,"slug":152},9,"Religion & Spirituality",20,"religion-spirituality",{"id":151,"doc_module":4,"doc_module_name":25,"category_name":154,"show_sort_weight":151,"slug":155},"World Cup","world-cup",{"id":157,"doc_module":4,"doc_module_name":25,"category_name":158,"show_sort_weight":157,"slug":159},10,"Lifestyle","lifestyle",{"id":92,"doc_module":4,"doc_module_name":25,"category_name":161,"show_sort_weight":131,"slug":162},"General","general"]